Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Lupin Limited
Press Release Feb 17 2022
Business
Feb 17 2022
5 min read

Press Release Feb 17 2022

Lupin Limited has informed the Exchange regarding a press release dated February 17, 2022, titled "Lupin Announces FDA Approval of Supplemental New Drug Application forSOLOSEC�� (secnidazole) in Adolescents for both the Treatment of BacterialVaginosis in Females and Trichomoniasis.".

View Attachment